Aspirin Export Market Intelligence: India's 327 Suppliers Shipping to 121 Countries — TransData Nexus 2026

Q: Who are the top aspirin exporters from India?

The top aspirin exporters from India are: 1. RECKITT BENCKISER (INDIA) PRIVATE LIMITED — $3.8M (9.9% market share); 2. CIPLA LIMITED — $2.5M (6.5% market share); 3. RECKITT BENCKISER INDIA PRIVATE LIMITED — $2.2M (5.8% market share); 4. ADCOCK INGRAM LIMITED — $1.9M (5.1% market share); 5. TRUECARE BIOMEDIX — $1.9M (5.0% market share). Together they account for 32.3% of India's total aspirin export value.

Q: What is the total export value of aspirin from India?

The total export value of aspirin from India is $37.8M USD, recorded across 3,422 shipment transactions from 327 active exporters to 121 destination countries. The average shipment value is $11.1K.

Q: Which countries import aspirin from India?

India exports aspirin to 121 countries worldwide. The top importing countries are: SOUTH AFRICA (32.4% share, $12.3M), UNITED STATES (26.6% share, $10.0M), NEW ZEALAND (5.0% share, $1.9M), AUSTRALIA (4.4% share, $1.6M), SRI LANKA (3.1% share, $1.2M). These five markets account for 71.5% of total export value.

Q: What is the HS code for aspirin exports from India?

The primary HS code for aspirin exports from India is 30049062. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of aspirin exports from India?

The average unit price for aspirin exports from India is $7.83 USD per unit, with prices ranging from $0.00 to $425.49 depending on formulation, packaging, and order volume. The total market is valued at $37.8M across 3,422 shipments.

Q: Which ports handle aspirin exports from India?

The primary ports for aspirin exports from India are BANGALORE ICD (12.4% of shipments), SAHAR AIR (12.4% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.9% of shipments), NHAVA SHEVA SEA (INNSA1) (10.2% of shipments), JNPT/ NHAVA SHEVA SEA (4.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of aspirin?

India is one of the world's leading exporters of aspirin due to its large base of 327 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports aspirin to 121 countries, demonstrating 62% global market coverage.

Q: What certifications do Indian aspirin exporters need?

Indian aspirin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import aspirin from India?

There are 805 registered buyers importing aspirin from India, spread across 121 countries. The repeat buyer rate is 47.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top aspirin supplier from India?

RECKITT BENCKISER (INDIA) PRIVATE LIMITED is the leading aspirin exporter from India with a market share of 9.9% and total export value of $3.8M across 268 shipments. The top 5 suppliers together control 32.3% of total export value.

Suresh Sormare

Aspirin

India Pharmaceutical Trade Intelligence

$37.8M327 Suppliers121 CountriesHS 30049062

ExportsIndia → SOUTH AFRICA32.4%India → UNITED STATES26.6%

ImportsCHINA → India$36.0M GERMANY → India$8.5K

#1 Supplier: RECKITT BENCKISER #1 Buyer: RECKITT BENCKISER

Aspirin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Aspirin to the World

Between 2022 and 2026, India exported $37.8M worth of aspirin across 3,422 verified shipments to 121 countries — covering 62% of world markets in the Analgesics & Antipyretics segment. The largest destination is SOUTH AFRICA (32.4%). RECKITT BENCKISER (INDIA) PRIVATE LIMITED leads with a 9.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Aspirin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Aspirin export data snapshot — $37.8M · 327 exporters · 121 countriesTransData Nexus · Indian Customs Data

Top Aspirin Exporters from India

327 active exporters · Ranked by export value

View all 327 →

Top Aspirin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	RECKITT BENCKISER (INDIA) PRIVATE LIMITED	$3.8M	268	2	9.9%
2	CIPLA LIMITED

Top Countries Importing Aspirin from India

121 destination markets · Ranked by import value

All 121 countries →

Top Countries Importing Aspirin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SOUTH AFRICA	$12.3M	32.4%
2	UNITED STATES	$10.0M	26.6%
3	NEW ZEALAND	$1.9M	5.0%
4	AUSTRALIA	$1.6M	4.4%
5	SRI LANKA	$1.2M	3.1%
6	ALGERIA	$1.1M	2.9%
7	GUINEA	$1.1M	2.9%
8	UNITED KINGDOM	$799.3K	2.1%
9	IRAQ	$774.7K	2.0%
10	UNITED ARAB EMIRATES	$679.5K	1.8%

SOUTH AFRICA is India's largest aspirin export destination, absorbing 32.4% of total exports worth $12.3M. The top 5 importing countries — SOUTH AFRICA, UNITED STATES, NEW ZEALAND, AUSTRALIA, SRI LANKA — together account for 71.5% of India's total aspirin export value. The remaining 116 destination countries collectively receive the other 28.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Aspirin to India?

11 origin countries · Total import value: $36.0M

India imports aspirin from 11 countries with a combined import value of $36.0M. The largest supplier is CHINA ($36.0M, 9 shipments), followed by GERMANY and THAILAND. All values are from Indian Customs (DGFT) import records.

Countries Supplying Aspirin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CHINA	$36.0M	9	99.9%
2	GERMANY	$8.5K	4	0.0%
3	THAILAND	$5.5K	1	0.0%
4	UNITED KINGDOM	$4.6K	6	0.0%
5	BELGIUM	$3.8K	1	0.0%
6	MALTA	$2.5K	5	0.0%
7	UNITED STATES	$259	3	0.0%
8	ISRAEL	$162	2	0.0%
9	SOUTH AFRICA	$83	3	0.0%
10	CANADA	$34	2	0.0%

Showing top 10 of 11 origin countries

CHINA is the largest supplier of aspirin to India, accounting for 99.9% of total import value. The top 5 origin countries — CHINA, GERMANY, THAILAND, UNITED KINGDOM, BELGIUM — together supply 100.0% of India's aspirin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Aspirin — Export Intelligence Video

Visual overview of India's aspirin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's aspirin pharmaceutical import and export market — $37.8M in total trade, 327 verified manufacturers, and 121 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Aspirin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, aspirin is regulated by the Food and Drug Administration (FDA). As a well-established drug, numerous Abbreviated New Drug Applications (ANDAs) have been approved for generic versions of aspirin, reflecting its widespread acceptance and use. The FDA's Orange Book provides a comprehensive list of these approved ANDAs, indicating the extensive generic competition in the market.

Regarding import alerts, the FDA issues these to prevent the entry of products that appear to violate regulations. As of March 2026, there are no specific import alerts related to aspirin from India. However, manufacturers and exporters must remain vigilant, as the FDA can impose import alerts if products are found to be non-compliant with U.S. standards. The regulatory pathway for aspirin involves compliance with the FDA's Current Good Manufacturing Practice (CGMP) regulations and ensuring that all labeling and marketing practices adhere to FDA guidelines. Given the 327 active Indian exporters, maintaining stringent quality control measures is imperative to ensure continued market access.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), aspirin is subject to regulation by the European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA), respectively. Marketing authorization for aspirin-containing products requires adherence to the EU's Good Manufacturing Practice (GMP) standards. The EMA has approved various formulations of aspirin, both as monotherapy and in combination with other agents. For instance, the combination of clopidogrel and acetylsalicylic acid has been authorized for the prevention of atherothrombotic events. Manufacturers exporting to these regions must ensure compliance with the respective regulatory requirements, including obtaining the necessary marketing authorizations and adhering to GMP standards.

3WHO Essential Medicines & Global Standards

Aspirin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its significance in global health. This inclusion mandates that member countries ensure its availability and affordability. Additionally, aspirin must comply with international pharmacopoeia standards, including those set forth by the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards ensures the quality, safety, and efficacy of aspirin products in the global market.

4India Regulatory Classification

In India, aspirin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including aspirin, to ensure affordability. Manufacturers intending to export aspirin must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring that domestic supply is not adversely affected by export activities.

5Patent & Exclusivity Status

Aspirin, having been in use for over a century, is no longer under patent protection. This lack of exclusivity has led to a highly competitive market with numerous generic manufacturers producing and exporting aspirin globally. The absence of patent constraints facilitates easier market entry for new manufacturers but also necessitates stringent quality control to maintain market share.

6Recent Industry Developments

In the past 12 months, several developments have impacted the aspirin market:

1. API Price Fluctuations (June 2025): The Directorate General of Foreign Trade (DGFT) reported a 10% increase in the price of aspirin's active pharmaceutical ingredient (API) due to supply chain disruptions.

2. New Generic Approvals (September 2025): The FDA approved three new ANDAs for generic aspirin products, increasing competition in the U.S. market.

3. Policy Changes in Export Regulations (December 2025): The Indian Ministry of Commerce and Industry revised export policies, requiring additional documentation for pharmaceutical exports to ensure quality compliance.

4. EU GMP Certification (February 2026): An Indian manufacturer received EU GMP certification, facilitating easier access to European markets.

5. WHO Prequalification (March 2026): A leading Indian pharmaceutical company achieved WHO prequalification for its aspirin product, enhancing its credibility in international tenders.

These developments highlight the dynamic nature of the aspirin market and the importance of staying abreast of regulatory changes and market trends.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Aspirin

Retail & reference prices across 9 markets vs. India FOB export price of $7.83/unit

Global Price Benchmark for Aspirin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	Aspirin is available over-the-counter in the U.S., with prices varying by retailer and brand.
United Kingdom	$0.11	GBP	Aspirin is listed in the NHS Drug Tariff, which sets reimbursement prices for medications.
Germany	$0.10	EUR	Aspirin is regulated by the Federal Institute for Drugs and Medical Devices (BfArM).
Australia	$0.11	AUD

Supply Chain Risk Assessment — Aspirin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including aspirin production, heavily relies on imports for Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs), with over 70% sourced from China. This dependency exposes the supply chain to risks such as geopolitical tensions and trade restrictions. For instance, in July 2025, disruptions in Chinese supply chains led to a temporary shortage of critical APIs in India, highlighting the vulnerability of relying on a single source.

To mitigate these risks, the Indian government launched the Production Linked Incentive (PLI) Scheme for Bulk Drugs in July 2020, aiming to promote domestic manufacturing of critical KSMs, DIs, and APIs. By September 2025, the scheme had resulted in cumulative sales of ₹2,315 crore, including exports of ₹508 crore, thereby avoiding imports worth ₹1,807 crore. However, as of March 2026, aspirin's KSMs are not yet produced domestically under this scheme, leaving the supply chain susceptible to external disruptions.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters account for 32.3% of aspirin exports, with RECKITT BENCKISER (INDIA) PRIVATE LIMITED leading at a 9.9% share. This moderate concentration suggests a relatively diversified supplier base, reducing the risk associated with single-source dependency.

Access Complete Aspirin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,422 transactions across 121 markets.

Request Demo View Pricing

Frequently Asked Questions — Aspirin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top aspirin exporters from India?

The leading aspirin exporters from India are RECKITT BENCKISER (INDIA) PRIVATE LIMITED, CIPLA LIMITED, RECKITT BENCKISER INDIA PRIVATE LIMITED, and 12 others. RECKITT BENCKISER (INDIA) PRIVATE LIMITED leads with 9.9% market share ($3.8M). The top 5 suppliers together control 32.3% of total export value.

What is the total export value of aspirin from India?

The total export value of aspirin from India is $37.8M, recorded across 3,422 shipments from 327 active exporters to 121 countries. The average shipment value is $11.1K.

Which countries import aspirin from India?

India exports aspirin to 121 countries. The top importing countries are SOUTH AFRICA (32.4%), UNITED STATES (26.6%), NEW ZEALAND (5.0%), AUSTRALIA (4.4%), SRI LANKA (3.1%), which together account for 71.5% of total export value.

What is the HS code for aspirin exports from India?

The primary HS code for aspirin exports from India is 30049062. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Aspirin

Aspirin

Top Aspirin Exporters from India

Top Countries Importing Aspirin from India

Who Supplies Aspirin to India?

Quick Facts

Related Analgesics & Antipyretics

Related Analysis

Need Details?

Aspirin — Export Intelligence Video

Regulatory Landscape — Aspirin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Aspirin

Supply Chain Risk Assessment — Aspirin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Aspirin Trade Intelligence

Frequently Asked Questions — Aspirin Exports from India

Who are the top aspirin exporters from India?

What is the total export value of aspirin from India?

Which countries import aspirin from India?

What is the HS code for aspirin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of aspirin exports from India?

Which ports handle aspirin exports from India?

Why is India a leading exporter of aspirin?

What certifications do Indian aspirin exporters need?

How many buyers import aspirin from India?

What is the market share of the top aspirin exporter from India?

Analysis Methodology